Literature searching for clinical and cost-effectiveness studies used in health technology assessment reports carried out for the National Institute for Clinical Excellence appraisal system
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To contribute to making searching for Technology Assessment Reports (TARs) more cost-effective by suggesting an optimum literature retrieval strategy. DATA SOURCES: A sample of 20 recent TARs. REVIEW METHODS: All sources used to search for clinical and cost-effectiveness studies were recorded. In addition, all studies that were included in the clinical and cost-effectiveness sections of the TARs were identified, and their characteristics recorded, including author, journal, year, study design, study size and quality score. Each was also classified by publication type, and then checked to see whether it was indexed in the following databases: MEDLINE, EMBASE, and then either the Cochrane Controlled Trials Register (CCTR) for clinical effectiveness studies or the NHS Economic Evaluation Database (NHS EED) for the cost-effectiveness studies. Any study not found in at least one of these databases was checked to see whether it was indexed in the Science Citation Index (SCI) and BIOSIS, and the American Society of Clinical Oncology (ASCO) Online if a cancer review. Any studies still not found were checked to see whether they were in a number of additional databases. RESULTS: The median number of sources searched per TAR was 20, and the range was from 13 to 33 sources. Six sources (CCTR, DARE, EMBASE, MEDLINE, NHS EED and sponsor/industry submissions to National Institute for Clinical Excellence) were used in all reviews. After searching the MEDLINE, EMBASE and NHS EED databases, 87.3% of the clinical effectiveness studies and 94.8% of the cost-effectiveness studies were found, rising to 98.2% when SCI, BIOSIS and ASCO Online and 97.9% when SCI and ASCO Online, respectively, were added. The median number of sources searched for the 14 TARs that included an economic model was 9.0 per TAR. A sensitive search filter for identifying non-randomised controlled trials (RCT), constructed for MEDLINE and using the search terms from the bibliographic records in the included studies, retrieved only 85% of the known sample. Therefore, it is recommended that when searching for non-RCT studies a search is done for the intervention alone, and records are then scanned manually for those that look relevant. CONCLUSIONS: Searching additional databases beyond the Cochrane Library (which includes CCTR, NHS EED and the HTA database), MEDLINE, EMBASE and SCI, plus BIOSIS limited to meeting abstracts only, was seldom found to be effective in retrieving additional studies for inclusion in the clinical and cost-effectiveness sections of TARs (apart from reviews of cancer therapies, where a search of the ASCO database is recommended). A more selective approach to database searching would suffice in most cases and would save resources, thereby making the TAR process more efficient. However, searching non-database sources (including submissions from manufacturers, recent meeting abstracts, contact with experts and checking reference lists) does appear to be a productive way of identifying further studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some researchers agree that when timeliness is of importance, hand searching of reference lists and contacting experts can be more effective than comprehensive bibliographic database searches [45, 46].”
From How to conduct systematic reviews more expeditiously? (2015) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Consensus development methods, and their use in clinical guideline development.
Murphy, Black, Lamping, McKee, Sanderson, Askham, & Marteau (1998) · Health Technology Assessment · doi:10.3310/hta2030 · Cited by 2,051
Guidelines for authors and peer reviewers of economic submissions to the BMJ
Drummond, M. F., & Jefferson, T. O. (1996) · BMJ · doi:10.1136/bmj.313.7052.275 · Cited by 1,827
Evaluating patient-based outcome measures for use in clinical trials.
Fitzpatrick, Davey, Buxton, & Jones (1998) · Health Technology Assessment · doi:10.3310/hta2140 · Cited by 1,715
Egger, M., Jüni, P., Bartlett, C., Holenstein, F., & Sterne, J. (2003) · Health Technology Assessment · doi:10.3310/hta7010 · Cited by 1,181
Full publication of results initially presented in abstracts.
Scherer, R. W., Langenberg, P., & von Elm, E. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000005.pub3 · Cited by 997
Direction and impact of language bias in meta-analyses of controlled trials: empirical study
Jüni, P., Holenstein, F., Sterne, J., Bartlett, C., & Egger, M. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.115 · Cited by 892
The Medical Review Article: State of the Science
MULROW, C. D. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-3-485 · Cited by 856
Royle, P., & Milne, R. (2003) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462303000552 · Cited by 693
Self-citationJadad, A. R., Cook, D. J., Jones, A., Klassen, T. P., Tugwell, P., Moher, M., & Moher, D. (1998) · JAMA · doi:10.1001/jama.280.3.278 · Cited by 534
Research works printed but not linked: 7
- [16]16. Lee KP , Schotland M, Bacchetti P , Bero LA. Association of journal quality indicators with methodological quality of clinical research articles. JAMA 2002; 287 :2805-8.
- [18]18. Hopewell S, McDonald S, Clarke M, Egger M. Grey literature in meta-analyses of randomized trials of health care interventions (Cochrane Methodology Review). In The Cochrane Library (Issue 1). Oxford: Update Software; 2003.
- [22]22. Jefferson TO, Alderson P , Davidoff F, Wager E. Editorial peer-review for improving the quality of reports of biomedical studies (Cochrane Methodology Review). In The Cochrane Library (Issue 1). Oxford: Update Software; 2003.
- [36]36. Eady A. Secondary publications: economic analyses. In McKibbon A, editor. PDQ evidence-based principles and practice. Hamilton: Decker; 1999. pp. 173-86.
- [38]38. Clarke M, Oxman AD, editors. Locating and selecting studies. Cochrane Reviewers Handbook 4.1.6 (updated January 2003) Section 5. In The Cochrane Library (Issue 2). Oxford: Update Software; 2003.
- [40]40. Royle P . Literature searching for randomised controlled trials used in Cochrane reviews: rapid versus exhaustive searches [dissertation]. Southampton: University of Southampton; 2001.
- [41]41. Hopewell S, Clarke M, Stewart L, Tierney J. Time to publication for results of clinical trials (Cochrane Methodology Review). In The Cochrane Library (Issue 1). Oxford: Update Software; 2003.
Cited by
Items 101–194 of 194
Bond, M., Wyatt, K., Lloyd, J., Welch, K., & Taylor, R. (2009) · Health Technology Assessment · doi:10.3310/hta13610 · Cited by 39
Ademi, Z., Tomonaga, Y., van Stiphout, J., Glinz, D., Gloy, V., Raatz, H., Bucher, H. C., & Schwenkglenks, M. M. (2018) · Swiss Medical Weekly · doi:10.4414/smw.2018.14626 · Cited by 41
Waffenschmidt, S., Navarro, T., Hobson, N., Hausner, E., Sauerland, S., & Haynes, R. B. (2020) · Research Synthesis Methods · doi:10.1002/jrsm.1425 · Cited by 40
“The number of references used in previous analyses was quite limited: Fraser(4) tested their filters on 217 observational studies extracted from 1 systematic review and validated them against 69 references (included in 2 systematic reviews); the gold standard in Furlan(25) comprised 93 relevant references for testing…”
MethodUse of palivizumab in infants and young children with severe respiratory disease: A delphi study
Gaboli, M. P., la Cruz, O. A.-D., de Agüero, M. I. B. G., Moreno, A., Pérez, G., & Sánchez‐Solís, M. (2013) · Pediatric Pulmonology · doi:10.1002/ppul.22826 · Cited by 36
Dormandy, E., Bryan, S., Gulliford, M. C., Roberts, T. E., Ades, A. E., Calnan, M., Atkin, K. M., Karnon, J. D., Barton, P., Logan, J., et al. (2010) · Health Technology Assessment · doi:10.3310/hta14200 · Cited by 39
WHICH DATABASES SHOULD BE USED TO IDENTIFY STUDIES FOR SYSTEMATIC REVIEWS OF ECONOMIC EVALUATIONS?
Arber, M. R., Glanville, J., Isojärvi, J., Baragula, E., Edwards, M., Shaw, A., & Wood, H. (2018) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462318000636 · Cited by 37
“Royle and Waugh (10) and Alton et al. (8) both identified NHS EED as a key source for the identification of EEs, and its use is recommended in methods guidance (12;13).”
BackgroundResultSimpson, E. L., Stevenson, M., Rawdin, A., & Papaioannou, D. E. (2009) · Health Technology Assessment · doi:10.3310/hta13020 · Cited by 33
Preston, L., Carroll, C., Gardois, P., Paisley, S., & Kaltenthaler, E. (2015) · Systematic Reviews · doi:10.1186/s13643-015-0074-7 · Cited by 32
“%) of its included citations (even though all 14 Table 1 Included reviews Review Topic Number of included studies Number and names of databases searched Holmes (2014) Routine echocardiography in the management of stroke and transient ischemic attack (TIA) 51 (n = 9) MEDLINEa, EMBASE, CENTRAL, CDSR, NHS DARE, HTA, CINA…”
BackgroundInfluentialGubler-Gut, B., Pöhlmann, J., Flatz, A., Schwenkglenks, M. M., & Rohrmann, S. (2021) · Journal of Cancer Survivorship · doi:10.1007/s11764-021-01002-0 · Cited by 39
“Finally, bibliography mining and cited reference searches using reference lists was undertaken [36].”
MethodGuba, B. (2008) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-007-0500-0 · Cited by 49
Consenso de expertos sobre propuestas para la mejora del manejo de la dislipemia aterogénica
Núñez-Cortés, J. M., Pedro‐Botet, J., Brea-Hernando, Á., Rodríguez, Á. D., González‐Santos, P., Hernández‐Mijares, A., Mantilla, T., Pintó, X., & Simó, R. (2013) · Revista Española de Cardiología · doi:10.1016/j.recesp.2013.06.014 · Cited by 34
“Se aceptó que habı́a concordancia cuando menos de un tercio de los expertos puntuaban fuera de la región de tres puntos (1-3, 4-6, 7-9) en la que se situó la propia mediana; habı́a discordancia cuando las puntuaciones de un tercio o más de los panelistas estaban en la región 1-3, y de otro tercio o más en la región 7-…”
BackgroundTacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients
Penninga, L., Penninga, E. I., Møller, C. H., Steinbrüchel, D. A., & Gluud, C. N. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008817 · Cited by 29
Parker, S. G., Oliver, P., Pennington, M., Bond, J. B., Jagger, C., Enderby, P., Curless, R., Chater, T., Vanoli, A., Fryer, K., et al. (2009) · Health Technology Assessment · doi:10.3310/hta13390 · Cited by 30
Meléndez‐Torres, G. J., Auguste, P., Armoiry, X., Maheswaran, H., Court, R. A., Madan, J. J., Kan, A., Lin, S., Counsell, C. E., Patterson, J. V., et al. (2017) · Health Technology Assessment · doi:10.3310/hta21520 · Cited by 36
Cross, J., Elender, F., Barton, G., Clark, A., Shepstone, L., Blyth, A., Bachmann, M. O., & Harvey, I. M. (2010) · Health Technology Assessment · doi:10.3310/hta14230 · Cited by 38
Levay, P., Raynor, M., & Tuvey, D. (2015) · Evidence Based Library and Information Practice · doi:10.18438/b82p55 · Cited by 26
“Grey literature has previously been found to be a “productive way” of identifying further studies for a different NICE programme that appraises drugs and other health technologies (Royle & Waugh, 2003).”
BackgroundKarshima, S. N., Karshima, M. N., & Ahmed, M. I. (2021) · Pathogens and Global Health · doi:10.1080/20477724.2021.1989185 · Cited by 28
“This publication bias might be due to gap in literature arising from non-publication of results that contradict existing knowledge as well as dependence of research publication on the nature and direction of study results [125] and its statistical significance [126].”
ResultSearching CINAHL did not add value to clinical questions posed in NICE guidelines
Beckles, Z., Glover, S., Ashe, J., Stockton, S., Boynton, J., Lai, R., & Alderson, P. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.04.009 · Cited by 28
Identifying economic evaluations for health technology assessment
Glanville, J., & Paisley, S. (2010) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462310000991 · Cited by 24
“For EMBASE, high sensitivity filters were those developed by NHS Quality Improvement Scotland, CADTH, Royle and Waugh, and CRD (4;10;12;17).”
BackgroundMethodInfluentialAre adverse effects incorporated in economic models? An initial review of current practice.
Craig, D., Mcdaid, C., Fonseca, T., Stock, C., Duffy, S., & Woolacott, N. (2009) · Health Technology Assessment · doi:10.3310/hta13620 · Cited by 36
Sources of evidence for systematic reviews of interventions in diabetes
Royle, P. L., Bain, L., & Waugh, N. R. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01645.x · Cited by 24
Self-citationNewman, S. P., Cooke, D. D., Casbard, A. C., Walker, S., Meredith, S. K., Nunn, A., Steed, L., Manca, A., Sculpher, M., Barnard, M., et al. (2009) · Health Technology Assessment · doi:10.3310/hta13280 · Cited by 26
Bryant, J., Cooper, K., Picot, J., Clegg, A. J., Roderick, P., Rosenberg, W. M., & Patch, C. (2009) · Health Technology Assessment · doi:10.3310/hta13230 · Cited by 27
Lawani, M. A., Valéra, B., Fortier-Brochu, É., Légaré, F., Carmichael, P., Côté, L., Voyer, P., Kröger, E., Witteman, H. O., Rodríguez, C., et al. (2017) · Systematic Reviews · doi:10.1186/s13643-017-0446-2 · Cited by 24
“Some researchers have also previously reported that manual searches of reference lists and contacts with experts may be a more effective way to acquire information on all performed trials more quickly than through comprehensive bibliographic database searches [38, 39], since published reviews never include all trial r…”
BackgroundGiang, H. T. N., Ahmed, A. M., Fala, R. Y., Khattab, M. M., Othman, M., Abdelrahman, S. A. M., Le, T. P., Gabl, A. E. A. E., Elrashedy, S. A., Lee, P. N., et al. (2019) · BMC Medical Research Methodology · doi:10.1186/s12874-019-0780-2 · Cited by 24
“, CINAHL and PsycINFO), and web-based searching to locate grey literature [30].”
BackgroundNúñez-Cortés, J. M., Cases, A., Gimilio, J. F. A., Barrios, V., Fuster, V. P., Pedro‐Botet, J., Pintó, X., & Cumplido, A. S. (2016) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-016-0197-9 · Cited by 26
“A bibliographic search prioritising systematic reviews was conducted as well as another critical synthesis of scientific literature through the consultation of bibliographic databases (MEDLINE, EMBASE and the Spanish Medical Index) [27], and a manual review of the references obtained to find other references that may…”
MethodKarshima, S. N., Ahmed, M. I., Mohammed, K. M., Pam, V. A., Momoh, H. A., & Gwimi, B. P. (2022) · Veterinary Parasitology Regional Studies and Reports · doi:10.1016/j.vprsr.2022.100830 · Cited by 31
Rodgers, M., Hodges, R., Hawkins, J. E., Hollingworth, W., Duffy, S., McKibbin, M., Mansfield, M., Harbord, R. M., Sterne, J. A. C., Glasziou, P., et al. (2009) · Health Technology Assessment · doi:10.3310/hta13600 · Cited by 22
Takeda, A., Loveman, E., Harris, P., Hartwell, D., & Welch, K. (2008) · Health Technology Assessment · doi:10.3310/hta12320 · Cited by 21
(2006) · Europe PMC (PubMed Central) · Cited by 20
Paisley, S. (2016) · PharmacoEconomics · doi:10.1007/s40273-015-0372-x · Cited by 20
“tioning the value of searching a large number of databases [3, 11, 12].”
Sampson, M., Barrowman, N. J., Moher, D., Clifford, T., Platt, R. W., Morrison, A., Klassen, T. P., & Zhang, L. (2006) · BMC Medical Research Methodology · doi:10.1186/1471-2288-6-7 · Cited by 16
Rogowski, W. H., Burch, J., Palmer, S. C., Craigs, C., Golder, S., & Woolacott, N. F. (2009) · Health Technology Assessment · doi:10.3310/hta13310 · Cited by 15
Dundar, Y., Dodd, S. R., Williamson, P. R., Dickson, R., & Walley, T. (2006) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462306051166 · Cited by 16
Wright, J. M., Cottrell, D. J., & Mir, G. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.02.017 · Cited by 18
Searching for Evidence for Cost‐Effectiveness Decisions
Glanville, J., & Paisley, S. (2010) · Wiley eBooks · doi:10.1002/9781444320398.ch7 · Cited by 19
Bayesian Statistics for Surgical Decision Making
Hatton, G. E., Pedroza, C., & Kao, L. S. (2021) · Surgical Infections · doi:10.1089/sur.2020.391 · Cited by 19
“Step 2 Identify or perform a proper systematic review of the best available evidence [10,11] (any existing systematic reviews may be most easily identified using the clinical queries option of PubMed).”
The effects of biofeedback for the treatment of essential hypertension: a systematic review
Greenhalgh, J., Dickson, R., & Dundar, Y. (2009) · Health Technology Assessment · doi:10.3310/hta13460 · Cited by 15
Registered Randomized Trials Comparing Generic and Brand-Name Drugs: A Survey
Flacco, M. E., Manzoli, L., Boccia, S., Puggina, A., Rosso, A., Marzuillo, C., Scaioli, G., Gualano, M. R., Ricciardi, W., Villari, P., et al. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.04.032 · Cited by 17
Helfand, M. (2005) · Medical Care · doi:10.1097/01.mlr.0000170037.73154.8b · Cited by 15
Hausner, E., Metzendorf, M., Richter, B., Lotz, F., & Waffenschmidt, S. (2018) · BMC Medical Research Methodology · doi:10.1186/s12874-018-0625-4 · Cited by 14
“Search terms for finding non-RCTs (Royle 2003) [29] Non-RCT 2–12 8.”
Use of Expert Consensus to Improve Atherogenic Dyslipidemia Management
Núñez-Cortés, J. M., Pedro‐Botet, J., Brea-Hernando, Á., Rodríguez, Á. D., González‐Santos, P., Hernández‐Mijares, A., Mantilla, T., Pintó, X., & Simó, R. (2013) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.06.011 · Cited by 13
“For each item, we have detailed the central tendencies (median and mean scores) and the percentage of panelists that gave a score within the 3-point range that contained the median (1-3, 4-6, 7-9) (Table).”
BackgroundSYSTEMATIC REVIEWS OF ECONOMIC EVALUATIONS: HOW EXTENSIVE ARE THEIR SEARCHES?
Wood, H., Arber, M. R., & Glanville, J. (2017) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462316000660 · Cited by 12
Bobes, J., Sáiz, P. A., Bernardo, M., Martínez, F. C., Gilaberte, I., & Ciudad-Herrera, A. (2012) · PubMed · Cited by 16
Antibody induction therapy for lung transplant recipients
Penninga, L., Møller, C. H., Penninga, E. I., Iversen, M., Gluud, C. N., & Steinbrüchel, D. A. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008927 · Cited by 13
USING THE AMSTAR CHECKLIST FOR RAPID REVIEWS: IS IT FEASIBLE?
Mattivi, J. T., & Buchberger, B. (2016) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462316000465 · Cited by 13
Consenso multidisciplinar sobre dislipidemia aterogénica
Aterogénica, F. D. (2013) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2013.03.001 · Cited by 17
Guo, Q., Cheng, Y., Zhang, C., Yang, H., Chen, X., Wang, X., Liu, Y., Feng, K., Long, Y., Shao, Z., et al. (2022) · Research Synthesis Methods · doi:10.1002/jrsm.1581 · Cited by 13
Medrano, C., Garcı́a-Guereta, L., Piñeda, L. F., Concepción, P. M., Álvaro, E. M., de Soto, J. S., Casero, J. L., Cabrera, P. S., & Martínez, F. C. (2010) · Anales de Pediatría · doi:10.1016/j.anpedi.2010.03.001 · Cited by 10
Consenso de expertos sobre propuestas de información al paciente en tratamiento con sales de litio
González-Pinto, A. M., Balanzá‐Martínez, V., Hernández, A. B., Gutiérrez-Rojas, L., Montes, J. M. G., Perrino, C. D. D., Pérez, V., Montejo, A. L., Palomo, A. G., & Crespo, J. M. (2019) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2019.11.001 · Cited by 10
Economic evaluation databases as an aid to healthcare decision makers and researchers
Aguiar‐Ibáñez, R., Nixon, J., Glanville, J., Craig, D., Rice, S. J. C., Christie, J., & Drummond, M. (2005) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.5.6.721 · Cited by 9
Orme, M. E., Bentley, R., Marcella, S., Peck‐Radosavljevic, M., Perard, R., Wedemeyer, H. H., Yoshiji, H., Agarwal, K., & Dusheiko, G. M. (2022) · Advances in Therapy · doi:10.1007/s12325-022-02235-w · Cited by 7
“MEDLINE, EMBASE, PubMed (e-publications/ ahead-of-print/in process), CENTRAL (Cochrane Central Register of Controlled Trials), Cochrane Database of Systematic Reviews (CDSR), and UK National Institute for Health Research Health Technology Assessment (NIHR-HTA) were searched using a structured literature search from da…”
MethodEvidence-Based Decision-Making 3: Health Technology Assessment
O’Reilly, D. J., Campbell, K., Vanstone, M. G., Bowen, J. M., Schwartz, L. J., Assasi, N., & Goeree, R. A. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2428-8_25 · Cited by 7
Barrios, V., Escobar, C., Cortés, C. O., Cosín-Sales, J., Pascual-Figal, D. A., & Marimón, X. G.-M. (2020) · Revista Clínica Española · doi:10.1016/j.rce.2019.10.011 · Cited by 8
Boberg‐Ans, L. C., Klefter, O. N., Rasmussen, M. L. R., van Dijk, E. H. C., & Subhi, Y. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13060983 · Cited by 6
“Royle and Waugh showed that for randomized clinical trials that investigate cost-effectiveness, searching a single database did not yield sufficient coverage, but searching more databases in addition to the combination of the Cochrane Central, MEDLINE, EMBASE, Web of Science Core Collection, and BIOSIS Previews had li…”
BackgroundNixon, J., Duffy, S., Armstrong, N., Craig, D., Glanville, J., Christie, J., Drummond, M., & Kleijnen, J. (2004) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462304001059 · Cited by 6
Pedro‐Botet, J., Barrios, V., Pascual, V., Ascaso, J. F., Cases, A., Millán, J., Serrano, A., & Pintó, X. (2016) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2015.12.003 · Cited by 5
ASSESSING SEARCHES IN NICE SINGLE TECHNOLOGY APPRAISALS: PRACTICE AND CHECKLIST
Wong, R., Paisley, S., & Carroll, C. (2013) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462313000330 · Cited by 5
“Studies measuring the impact of errors in search strategies, and the importance of the evidence on precision and recall, have found that where there are mistakes in the search strategies, the effectiveness of the retrieval process is reduced (12;24).”
BackgroundSearching for and use of conference abstracts in health technology assessments: Policy and practice
Dundar, Y., Dodd, S. R., Williamson, P. R., Walley, T., & Dickson, R. (2006) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462306051154 · Cited by 4
“, handsearching of journal supplements, meeting abstract books, and conference sites) (11;12).”
BackgroundEvidence-Based Decision Making 3: Health Technology Assessment
O’Reilly, D. J., Audas, R. P., Campbell, K., Vanstone, M. G., Bowen, J. M., Schwartz, L. J., Assasi, N., & Goeree, R. A. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1138-8_23 · Cited by 4
Basics of Health Technology Assessment
O’Reilly, D. J., Campbell, K., & Goeree, R. A. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-385-1_16 · Cited by 6
Implementation of an Evidence-Based Care Program Within a Multihospital Health Care System
Guth, R. M., Herring, A. A., & Merz, L. R. (2018) · American Journal of Medical Quality · doi:10.1177/1062860618789360 · Cited by 4
Metasearch: A Web-Based Application to Perform Systematic Reviews
Crema, R. S., Neto, G. N. N., & Nohama, P. (2022) · Lecture notes in networks and systems · doi:10.1007/978-3-031-18344-7_56 · Cited by 4
Gutiérrez‐Ibarluzea, I., & Arana‐Arri, E. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00156 · Cited by 5
“Nevertheless, searching the CRD is a recognized source when retrieving HTA reports or studies on effectiveness and cost-effectiveness (Royle and Waugh, 2003) from HTA doers and main agencies include their reports or articles in the three main databases comprised under the CRD interface (DARE,…”
BackgroundKoch, K., & Lange, S. (2009) · The European Journal of Health Economics · doi:10.1007/s10198-008-0142-1 · Cited by 3
Thyregod, H. G. H., Møller, C. H., Søndergaard, L., Gluud, C. N., & Steinbrüchel, D. A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010488 · Cited by 3
RetractedExpert consensus on information sheet proposals for patients under treatment with lithium
González-Pinto, A. M., Balanzá‐Martínez, V., Hernández, A. B., Gutiérrez-Rojas, L., Montes, J. M. G., Perrino, C. D. D., Pérez, V., Montejo, A. L., Palomo, A. G., & Crespo, J. M. (2021) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/j.rpsmen.2021.03.003 · Cited by 3
Finding the Evidence for Decision Analytic Cost Effectiveness Models
Edlin, R. P., McCabe, C. J., Hulme, C. T., Hall, P. S., & Wright, J. M. (2015) · Springer eBooks · doi:10.1007/978-3-319-15744-3_2 · Cited by 2
Reviving the corporate medical library: using technology to become a cost center.
Hersey, D. (2006) · Europe PMC (PubMed Central) · Cited by 2
Cases, A., Pedro‐Botet, J., Fuster, V. P., Alonso, V. B., Pintó, X., Gimilio, J. F. A., Núñez-Cortés, J. M., & Cumplido, A. S. (2016) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2017.01.007 · Cited by 4
Cases, A., Pedro‐Botet, J., Fuster, V. P., Barrios, V., Pintó, X., Gimilio, J. F. A., Núñez-Cortés, J. M., & Cumplido, A. S. (2016) · Nefrología · doi:10.1016/j.nefro.2016.07.002 · Cited by 3
Vinyoles, E., Galgo, A., Albarrán, O. G., & Rodríguez‐Fortúnez, P. (2016) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2016.09.004 · Cited by 2
Kleijnen, J., & BEKKERING, T. (2009) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0028-1124002 · Cited by 2
Schünemann, H. J., Kunz, R., & Falck-Ytter, Y. T. (2009) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0028-1124001 · Cited by 2
Health technology assessment in cancer: A personal view from public health
Waugh, N. R. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.08.009 · Cited by 2
Self-citationImmunosuppressive T-cell antibody induction therapy for heart transplant recipients
Penninga, L., Møller, C. H., Gustafsson, F., Gluud, C. N., & Steinbrüchel, D. A. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008842 · Cited by 3
Serrano, A., & Pascual, V. (2016) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2016.07.007 · Cited by 1
Ryan, J., Biesty, L., Simiceva, A., Devane, D., Eppich, W., Kavanagh, D. O., Taneri, P. E., & McNamara, D. A. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-100883 · Cited by 1
“24 25 We developed our review question using the SPIDER tool.”
Gavan, S. P., Payne, K., Dixon, W. G., van der Veer, S. N., Tam, A. C. T., & Bansback, N. J. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01898-3 · Cited by 1
“Medline and Embase were appropriate databases to search because earlier studies found that the majority of published economic evaluations were indexed on these platforms 41 .”
A Primer in Technology Assessment
Ackerman, M. (2006) · AACN Advanced Critical Care · doi:10.1097/00044067-200604000-00004 · Cited by 1
Management of patients with heart failure treated in cardiology consultations: IC-BERG Study
Barrios, V., Escobar, C., Cortés, C. O., Cosín-Sales, J., Pascual-Figal, D. A., & Marimón, X. G.-M. (2020) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2019.10.007 · Cited by 1
Antibody immunosuppression for pancreas and kidney-pancreas transplant recipients
Penninga, L., Webster, A. C., Egfjord, M., Steinbrüchel, D. A., & Gluud, C. N. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004681
RetractedKhatcheressian, J. L., & Smith, T. J. (2006) · Springer eBooks · doi:10.1007/0-387-31056-8_11
Mammalian target of rapamycin inhibitors for heart transplant patients
Møller, C. H., Gustafsson, F., Gluud, C. N., & Penninga, L. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011206.pub2
Koch, K., & Lange, S. (2009) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0028-1124000
Should we consider Embase in Latin America?
Sampson, M., Barrowman, N. J., Moher, D., Platt, R. W., & John, P. D. S. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.02.006
Non-operative versus operative treatment for grade III to V blunt pancreatic trauma in children
Haugaard, M. V., Penninga, L., Gluud, C. N., & Wettergren, A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009746
Clinical use of ipilimumab for metastatic melanoma in Spain: towards a more consistent approach
Martín‐Algarra, S., de la Cruz‐Merino, L., Soriano, V., Manzano, J. L., & Espinosa, E. (2016) · Clinical & Translational Oncology · doi:10.1007/s12094-016-1484-2
“Supported by an independent methodological advisor, the scientific committee designed the items in the questionnaire based on a systematic review of data bases, including Medline, Embase and IME [24], and on a manual review of the references.”
MethodWood, H., Arber, M. R., & Glanville, J. (2014) · Value in Health · doi:10.1016/j.jval.2014.08.1964
Health Technology Assessment. Literature Review.
Rozmarinová, J. (2020) · doi:10.5817/cz.muni.p210-9646-2020-12
(2006) · Elsevier eBooks · doi:10.1016/b978-012370464-1.50014-9
Mammalian target of rapamycin inhibitors for heart transplant patients
Penninga, E. I., Møller, C. H., Gustafsson, F., Gluud, C. N., & Penninga, L. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011206
RetractedThyregod, H. G. H., Møller, C. H., Søndergaard, L., Gluud, C. N., & Steinbrüchel, D. A. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010488.pub2
Value of information analyses for advanced cell therapies: a systematic review
Heaps, A., & Gavan, S. P. (2026) · Health Economics Review · doi:10.1186/s13561-026-00728-w
“These two databases were sufficient because the majority of health economic evaluations can be found within their records [32].”
Metadata
- Authors
- Royle, P., & Waugh, N.
- Affiliations
- University of Aberdeen (GB)
- ORCID
- Waugh, N
- Venue
- Health Technology Assessment
- Published
- 2003-11
- Volume
- 7
- Issue
- 34
- Pages
- iii, ix-x, 1
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- OpenAlex
- W2119297205
- Cited by
- 194
- References
- 37
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 4 · 2021: 6 · 2020: 4 · 2019: 3 · 2018: 4 · 2017: 8 · 2016: 12 · 2015: 9 · 2014: 3 · 2013: 13 · 2012: 5
- FWCI
- 13.24
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Health Technology Assessment (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Warwick Research Archive Portal (University of Warwick) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- University of Warwick (cc-by)
- Funders
- Health Technology Assessment programme (02/30/01)
- Topics
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Social Sciences › Library and Information Sciences › scientometrics and bibliometrics research
- Keywords
- literature searching, National Institute for Clinical Excellence, database indexing, MEDLINE, Embase, search filters, economic models, bibliographic databases, BIOSIS
- MeSH terms
- Abstracting and Indexing, Cost-Benefit Analysis, United Kingdom, Medical Informatics, Research Design, Technology Assessment, Biomedical, Randomized Controlled Trials as Topic, Databases, Bibliographic, Information Storage and Retrieval
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.